Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramFátima Cardoso, Sharon H. Giordano, Melissa P. Murray et al.|Annals of Oncology|2017Cited by 396
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?Stefan Aebi, Aron Goldhirsch, Shari Gelber et al.|The Lancet|2000Cited by 286
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023Giuseppe Curigliano, B. Xu, Marleen Kok et al.|Annals of Oncology|2023Cited by 218
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXStefan Aebi, Aron Goldhirsch, Zijie Sun et al.|Annals of Oncology|2011Cited by 55
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumoursDaniel R. Zwahlen, Stefan Aebi|International Journal of Cancer|2000Cited by 40